Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflicts of interest: Akimasa Sekine has received honoraria for lectures from AstraZeneca, Ono, Eli Lily and Boehringer Ingelheim, outside the submitted work.
Conflicts of interest: Satoshi Ikeda has received research funds from Chugai Pharmaceutical Co, Ltd. and AstraZeneca K.K., outside the submitted work. Honoraria received for lectures from Chugai Pharmaceutical Co, Ltd., Ono Pharmaceutical Co, Ltd., Boehringer Ingelheim, Eli Lilly K.K, Bristol-Myers Squibb, AstraZeneca K.K., Pfizer and Taiho Pharma, outside the submitted work.
Conflicts of interest: Tomohisa Baba has received Honoraria for lectures from AstraZeneca, Daiichi-Sankyo and Boehringer Ingelheim, outside the submitted work.
Conflicts of interest: Takashi Ogura has received Honoraria for lectures from Shionogi, Eisai and Boehringer Ingelheim, outside the submitted work.
Conflicts of interest: Yuriko Ishida has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received March 1, 2022.
- Accepted July 28, 2022.
- Copyright ©The authors 2022
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org